Related Experiment Video

Updated: Sep 25, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Chronic inflammatory demyelinating polyneuropathy in childhood

A M Connolly1

  • 1Department of Neurology, St. Louis Children's Hospital, Washington University of Medicine, St. Louis, Missouri 63110, USA.

Pediatric Neurology
|April 13, 2001
PubMed

Insights

Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is a rare condition causing progressive weakness. Diagnosis involves clinical signs, electrophysiology, and spinal fluid analysis for effective management.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder affecting children.
  • It presents with subacute onset of weakness, typically over two months, potentially leading to loss of ambulation.
  • Initial symptoms can resemble Guillain-Barré syndrome, with dysesthesias being common.

Purpose of the Study:

  • To review the clinical presentation, diagnosis, and prognosis of CIDP in children.
  • To discuss treatment options and immunologic features associated with childhood CIDP.

Main Methods:

  • Review of existing literature on childhood CIDP.
  • Analysis of clinical findings, electrophysiological studies, and cerebrospinal fluid examination.
  • Discussion of treatment strategies and immunological aspects.

Main Results:

  • CIDP in children is characterized by proximal greater than distal weakness and diminished reflexes.
  • Electrophysiology confirms demyelination, and spinal fluid shows albuminocytologic dissociation.
  • Males are more frequently affected than females, with antecedent illnesses or vaccinations in about half of cases.

Conclusions:

  • Childhood CIDP requires a comprehensive approach for diagnosis and management.
  • Understanding the clinical course, diagnostic markers, and treatment options is crucial for improving patient outcomes.
  • Further research into immunologic features may offer targeted therapies.

More Related Videos

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...